Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Levetiracetam
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 250 mg
- Dosage form
- Tablet
- Pack
- 3x10's
- Registration no.
- 061773
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Vicet 250 mg tablet
Vicet 250 mg tablet contains Levetiracetam 250 mg. It is registered with DRAP by Martin Dow Marker Limited (registration no. 061773). Its official price is PKR 1,627.48 for a pack of 3x10's, about PKR 54.25 per tablet. This price has applied since 23 July 2026. Vicet is also available as 500 mg tablet. 57 other brands of Levetiracetam 250 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Vicet
Other brands of Levetiracetam 250 mg
Official price over time
No change in the official DRAP price is recorded for this pack (3x10's). Current price PKR 1,627.48, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Vicet 250 mg, 3x10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/vicet-250-mg-061773-3x10s-martin-dow-marker-limited/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,627.48 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 061773Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
